Neeta Singla

1.3k total citations
38 papers, 681 citations indexed

About

Neeta Singla is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Neeta Singla has authored 38 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Infectious Diseases, 27 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Neeta Singla's work include Tuberculosis Research and Epidemiology (33 papers), Pneumonia and Respiratory Infections (19 papers) and Pneumocystis jirovecii pneumonia detection and treatment (11 papers). Neeta Singla is often cited by papers focused on Tuberculosis Research and Epidemiology (33 papers), Pneumonia and Respiratory Infections (19 papers) and Pneumocystis jirovecii pneumonia detection and treatment (11 papers). Neeta Singla collaborates with scholars based in India, France and United States. Neeta Singla's co-authors include Digamber Behera, Rupak Singla, Rohit Sarin, Rajiv Sarin, Poonam Sharma, Rupak Singla, Vithal Prasad Myneedu, Sangeeta Sharma, V.K. Arora and Vikram Vohra and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Neeta Singla

38 papers receiving 624 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neeta Singla India 18 572 403 204 46 45 38 681
Malik Parmar India 17 739 1.3× 567 1.4× 171 0.8× 44 1.0× 42 0.9× 46 848
Dag Gundersen Storla Norway 7 662 1.2× 495 1.2× 226 1.1× 49 1.1× 57 1.3× 9 794
Ikushi Onozaki Japan 9 526 0.9× 388 1.0× 223 1.1× 24 0.5× 20 0.4× 16 591
D. F. Wares India 15 448 0.8× 339 0.8× 125 0.6× 23 0.5× 31 0.7× 27 541
Dinh Ngoc Sy Vietnam 16 717 1.3× 580 1.4× 265 1.3× 19 0.4× 32 0.7× 27 794
Sidney Atwood United States 14 578 1.0× 479 1.2× 242 1.2× 18 0.4× 96 2.1× 27 904
Kiran Rade India 14 467 0.8× 288 0.7× 77 0.4× 67 1.5× 37 0.8× 41 596
Yunzhou Ruan China 10 506 0.9× 418 1.0× 202 1.0× 75 1.6× 29 0.6× 15 640
A Thomas India 9 412 0.7× 316 0.8× 134 0.7× 18 0.4× 48 1.1× 16 496
K Jaggarajamma India 9 385 0.7× 269 0.7× 114 0.6× 25 0.5× 54 1.2× 17 446

Countries citing papers authored by Neeta Singla

Since Specialization
Citations

This map shows the geographic impact of Neeta Singla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neeta Singla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neeta Singla more than expected).

Fields of papers citing papers by Neeta Singla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neeta Singla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neeta Singla. The network helps show where Neeta Singla may publish in the future.

Co-authorship network of co-authors of Neeta Singla

This figure shows the co-authorship network connecting the top 25 collaborators of Neeta Singla. A scholar is included among the top collaborators of Neeta Singla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neeta Singla. Neeta Singla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Singla, Rupak, Raman Mahajan, Homa Mansoor, et al.. (2025). Bedaquiline Resistance and Treatment Outcomes Among Patients With Tuberculosis Previously Exposed to Bedaquiline in India: A Multicentric Retrospective Cohort Study. Clinical Infectious Diseases. 81(4). 846–852. 1 indexed citations
2.
Philip, Sairu, Tanu Anand, Palanivel Chinnakali, et al.. (2024). Situation Analysis of Early Implementation of Programmatic Management of Tuberculosis Preventive Treatment among Household Contacts of Pulmonary TB Patients in Delhi, India. Tropical Medicine and Infectious Disease. 9(1). 24–24. 4 indexed citations
4.
Singhal, Ritu, et al.. (2023). Chronic pulmonary aspergillosis in a tertiary tuberculosis institute: A common entity missed commonly. Indian Journal of Tuberculosis. 70(3). 276–285. 3 indexed citations
5.
Singla, Rupak, et al.. (2022). Factors affecting the treatment outcome of injection based shorter MDR-TB regimen at a referral centre in India. Monaldi Archives for Chest Disease. 93(3). 4 indexed citations
6.
7.
Kumar, Rajesh, Neeta Singla, Tanu Anand, et al.. (2020). Nikshay Poshan Yojana (NPY) for tuberculosis patients: Early implementation challenges in Delhi, India. Indian Journal of Tuberculosis. 67(2). 231–237. 27 indexed citations
8.
Sharma, Nandini, et al.. (2020). Trends & treatment outcomes of multidrug-resistant tuberculosis in Delhi, India (2009-2014). The Indian Journal of Medical Research. 151(6). 598–603. 13 indexed citations
9.
Sharma, Nandini, Neeta Singla, Ashwani Khanna, et al.. (2019). Pattern and trends of drug sensitivity in MDR-TB cases in Delhi (2009–2014): A record based study. Indian Journal of Tuberculosis. 66(2). 222–226. 2 indexed citations
10.
Tripathy, Jaya Prasad, et al.. (2019). “99DOTS”techno-supervision for tuberculosis treatment – A boon or a bane? Exploring challenges in its implementation at a tertiary centre in Delhi, India. Indian Journal of Tuberculosis. 67(1). 46–53. 11 indexed citations
11.
Sarin, Rohit, et al.. (2019). Early efficacy and safety of Bedaquiline and Delamanid given together in a “Salvage Regimen” for treatment of drug-resistant tuberculosis. Indian Journal of Tuberculosis. 66(1). 184–188. 21 indexed citations
12.
Sarin, Rohit, Vikram Vohra, Neeta Singla, et al.. (2018). Identifying costs contributing to catastrophic expenditure among TB patients registered under RNTCP in Delhi metro city in India. Indian Journal of Tuberculosis. 66(1). 150–157. 26 indexed citations
13.
Singla, Rupak, et al.. (2017). Sequelae of pulmonary multidrug-resistant tuberculosis at the completion of treatment. Lung India. 35(1). 4–4. 24 indexed citations
14.
Singhal, Ritu, et al.. (2015). Multidrug-resistant tuberculosis among different types of suspected cases: Study from New Delhi. Indian Journal of Tuberculosis. 62(3). 183–186. 3 indexed citations
15.
Behera, Digambar, et al.. (2014). Impact of Sensitization on Knowledge and Attitude of Nurses in Tuberculosis. International Journal of Nursing Education. 6(1). 277–277. 2 indexed citations
16.
Singla, Neeta, Srinath Satyanarayana, Kuldeep Singh Sachdeva, et al.. (2014). Impact of Introducing the Line Probe Assay on Time to Treatment Initiation of MDR-TB in Delhi, India. PLoS ONE. 9(7). e102989–e102989. 36 indexed citations
17.
Singla, Rupak, et al.. (2013). Sputum smear positivity at two months in previously untreated pulmonary tuberculosis patients. SHILAP Revista de lepidopterología. 2(4). 199–205. 18 indexed citations
18.
Singla, Rupak, et al.. (2011). Linezolid: an effective, safe and cheap drug for patients failing multidrug-resistant tuberculosis treatment in India. European Respiratory Journal. 39(4). 956–962. 42 indexed citations
19.
Singla, Rupak, et al.. (2009). Risk factors for new pulmonary tuberculosis patients failing treatment under the Revised National Tuberculosis Control Programme, India.. PubMed. 13(4). 521–6. 29 indexed citations
20.
Singla, Rupak, Neeta Singla, Rohit Sarin, & V. K. Arora. (2005). Influence of Pre-Treatment Bacillary Load on Treatment Outcome of Pulmonary Tuberculosis Patients Receiving DOTS Under RNTCP. 25(5). 309–12. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026